Literature DB >> 27678299

Nocturnal Polyuria in Older Women with Urge Urinary Incontinence: Role of Sleep Quality, Time in Bed and Medications Used.

Shachi Tyagi1, Subashan Perera2, Becky D Clarkson2, Stasa D Tadic2, Neil M Resnick2.   

Abstract

PURPOSE: Nocturia is common and bothersome in older adults, especially those who are also incontinent. Since nocturnal polyuria is a major contributor, we examined factors associated with nocturnal polyuria in this population to identify those possibly amenable to intervention.
MATERIALS AND METHODS: We analyzed baseline data from 2 previously completed studies of urge urinary incontinence. The studies involved 284 women (mean age ± SD 72.9 ± 7.9 years) who also completed 3-day voiding diaries. Participants with a nocturnal polyuria index greater than 33% were categorized as having nocturnal polyuria (nocturnal polyuria index = nocturnal urinary volume per 24-hour urine volume). Associations between nocturnal polyuria and various demographic, clinical and sleep related parameters were determined.
RESULTS: Overall 55% of the participants had nocturnal polyuria. Multivariable regression analysis revealed that age, body mass index, use of angiotensin converting enzyme inhibitor/angiotensin receptor blocker, time spent in bed and duration of first uninterrupted sleep were independent correlates of nocturnal polyuria. Participants with a larger nocturnal excretion reported a shorter duration of uninterrupted sleep before first awakening to void and worse sleep quality despite spending similar time in bed.
CONCLUSIONS: Body mass index, use of angiotensin converting enzyme inhibitor/angiotensin receptor blockers, time in bed and duration of uninterrupted sleep before first awakening to void are independently associated with nocturnal polyuria in older women with urge urinary incontinence, and are potentially modifiable. These findings also confirm the association between sleep and nocturnal polyuria. Further studies should explore whether interventions to reduce nocturnal polyuria and/or increase the duration of uninterrupted sleep before first awakening to void would help to improve sleep quality in this population and thereby reduce or eliminate the need for sedative hypnotics.
Copyright © 2017 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aged; nocturia; polyuria; sleep stages

Mesh:

Substances:

Year:  2016        PMID: 27678299      PMCID: PMC5315607          DOI: 10.1016/j.juro.2016.09.080

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  30 in total

1.  The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society.

Authors:  P Van Kerrebroeck; P Abrams; D Chaikin; J Donovan; D Fonda; S Jackson; P Jennum; T Johnson; G R Lose; A Mattiasson; G L Robertson; J Weiss
Journal:  BJU Int       Date:  2002-12       Impact factor: 5.588

2.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

3.  Short time to first void is associated with lower whole-night sleep quality in nocturia patients.

Authors:  Donald L Bliwise; Tove Holm-Larsen; Sandra Goble; Jens Peter Nørgaard
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

Review 4.  A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis.

Authors:  Jean-Nicolas Cornu; Paul Abrams; Christopher R Chapple; Roger R Dmochowski; Gary E Lemack; Martin C Michel; Andrea Tubaro; Stephan Madersbacher
Journal:  Eur Urol       Date:  2012-07-20       Impact factor: 20.096

5.  Sleeping well, aging well: a descriptive and cross-sectional study of sleep in "successful agers" 75 and older.

Authors:  Henry C Driscoll; Linda Serody; Susan Patrick; Jennifer Maurer; Salem Bensasi; Patricia R Houck; Sati Mazumdar; Eric A Nofzinger; Bethany Bell; Robert D Nebes; Mark D Miller; Charles F Reynolds
Journal:  Am J Geriatr Psychiatry       Date:  2007-12-10       Impact factor: 4.105

6.  The effects of age, metabolic syndrome, nocturnal polyuria and sleep disorders on nocturia.

Authors:  Hasan S Sağlam; C Serkan Gökkaya; Remzi Salar; Ali Memiş; Oztuğ Adsan
Journal:  Adv Clin Exp Med       Date:  2013 Jul-Aug       Impact factor: 1.727

7.  Impact of obesity on urinary storage symptoms: results from the FINNO study.

Authors:  Camille P Vaughan; Anssi Auvinen; Rufus Cartwright; Theodore M Johnson; Riikka M Tähtinen; Mika A Ala-Lipasti; Teuvo L J Tammela; Alayne D Markland; Kristian Thorlund; Kari A O Tikkinen
Journal:  J Urol       Date:  2012-10-24       Impact factor: 7.450

Review 8.  The hyperarousal model of insomnia: a review of the concept and its evidence.

Authors:  Dieter Riemann; Kai Spiegelhalder; Bernd Feige; Ulrich Voderholzer; Mathias Berger; Michael Perlis; Christoph Nissen
Journal:  Sleep Med Rev       Date:  2009-05-28       Impact factor: 11.609

9.  The effect of angiotensin inhibition on urinary incontinence: data from the National Health and Nutrition Examination Survey (2001-2008).

Authors:  Christopher S Elliott; Craig V Comiter
Journal:  Neurourol Urodyn       Date:  2013-08-29       Impact factor: 2.696

Review 10.  Urine concentrating and diluting ability during aging.

Authors:  Jeff M Sands
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-05-15       Impact factor: 6.053

View more
  1 in total

1.  A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy.

Authors:  Ho Song Yu; Jeong Woo Lee; Jihyeong Yu; Min Chul Cho; Sung Yong Cho
Journal:  Int Neurourol J       Date:  2019-12-31       Impact factor: 2.835

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.